The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
You're really the CEO of the system.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
You're really the CEO of the system.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Were you nervous? I mean, when they called you and said, you've got the job, was there a moment where you thought, have I bit off more than I can chew? This is a huge responsibility.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Were you nervous? I mean, when they called you and said, you've got the job, was there a moment where you thought, have I bit off more than I can chew? This is a huge responsibility.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Because you're an outsider, you were an alum, but you weren't coming up through the ranks as the CEO of the hospital or something.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Because you're an outsider, you were an alum, but you weren't coming up through the ranks as the CEO of the hospital or something.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
So tell me about the budget of UCSF. Because it's a state school, presumably California provides what fraction of it?
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
So tell me about the budget of UCSF. Because it's a state school, presumably California provides what fraction of it?
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
So what's the benefit of being a UC?
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
So what's the benefit of being a UC?
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
So in that sense, you and Stanford aren't that far apart.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
So in that sense, you and Stanford aren't that far apart.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Show me the P&L on those things there. So NIH is bringing in how much? Oh, gosh. Percentage-wise, roughly.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Show me the P&L on those things there. So NIH is bringing in how much? Oh, gosh. Percentage-wise, roughly.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
A third of the revenue for general operations is coming out of the NIH overhead. And then clinical revenue.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
A third of the revenue for general operations is coming out of the NIH overhead. And then clinical revenue.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Okay. And then philanthropy is some direct, some into the endowment where you're living off the interest.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
Okay. And then philanthropy is some direct, some into the endowment where you're living off the interest.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
And that's basically what your revenue streams are, those four things.
The Peter Attia Drive
#346 - Scaling biotech and improving global health: lessons from an extraordinary career in medicine | Susan Desmond-Hellmann, M.D., M.P.H.
And that's basically what your revenue streams are, those four things.